• Guideline Summary
  • NGC:009635
  • 2013 Jan

Toxoplasmosis in pregnancy: prevention, screening, and treatment.

  • Guideline Summary
  • NGC:009891
  • 2007 May (revised 2013 May)

Feverish illness in children: assessment and initial management in children younger than 5 years.

  • Guideline Summary
  • NGC:009226
  • 1999 (revised 2012)

ACR Appropriateness Criteria® headache — child.

  • Guideline Summary
  • NGC:010158
  • 1996 (revised 2013)

ACR Appropriateness Criteria® headache.

  • Guideline Summary
  • NGC:009365
  • 2012 Oct

EFNS-ENS guidelines for the use of PCR technology for the diagnosis of infections of the nervous system.

  • Guideline Summary
  • NGC:009361
  • 2004 Feb (revised 2012 Jan)

Nystagmus and oscillopsia.

  • Guideline Summary
  • NGC:009359
  • 2007 Jan (revised 2012 Sep)

EFNS-ENS guidelines on the diagnosis and management of disorders associated with dementia.

  • Guideline Summary
  • NGC:010489
  • 1999 Jun 27 (revised 2014 Feb)

Practice parameter for the assessment and treatment of children and adolescents with autism spectrum disorder.

  • Guideline Summary
  • NGC:009667
  • 1995 (revised 2012)

ACR Appropriateness Criteria® seizures — child.

  • Guideline Summary
  • NGC:009242
  • 1995 (revised 2012)

ACR Appropriateness Criteria® sinusitis — child.

  • Guideline Summary
  • NGC:009237
  • 1999 (revised 2012)

ACR Appropriateness Criteria® ataxia.

  • Guideline Summary
  • NGC:009252
  • 2009 (revised 2012)

ACR Appropriateness Criteria® cranial neuropathy.

  • Guideline Summary
  • NGC:008985
  • 2004 Oct (revised 2012 Jan)

The epilepsies: the diagnosis and management of the epilepsies in adults and children in primary and secondary care.

  • Guideline Summary
  • NGC:009625
  • 1998 Aug (revised 2013 Jan)

Diagnosis and treatment of headache.

  • Guideline Summary
  • NGC:009626
  • 1994 Jun (revised 2013 Jan)

Diagnosis and treatment of respiratory illness in children and adults.

  • Guideline Summary
  • NGC:009999
  • 2013 Oct

Guideline on the prevention of secondary central nervous system lymphoma.